BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20817095)

  • 21. Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
    Ahmad E; Steinberg SM; Goldin L; Hess CJ; Caporaso N; Kreitman RJ; Wiestner A; Wilson W; White T; Marti G; Stetler-Stevenson M
    Cytometry B Clin Cytom; 2008 Jul; 74(4):221-6. PubMed ID: 18431797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.
    Poggi A; Prevosto C; Catellani S; Rocco I; Garuti A; Zocchi MR
    Br J Haematol; 2010 Nov; 151(3):252-64. PubMed ID: 20813004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
    Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
    Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Porteous A; Nicolle A; Proctor SJ; Anderson JJ; Summerfield G
    Int J Oncol; 2008 Jul; 33(1):169-74. PubMed ID: 18575763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d.
    Dal Bo M; Tissino E; Benedetti D; Caldana C; Bomben R; Del Poeta G; Gaidano G; Rossi FM; Zucchetto A; Gattei V
    Semin Hematol; 2014 Jul; 51(3):168-76. PubMed ID: 25048781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
    Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S
    Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
    Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M
    Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphocytic leukemia cells express CD38 in response to Th1 cell-derived IFN-γ by a T-bet-dependent mechanism.
    Bürgler S; Gimeno A; Parente-Ribes A; Wang D; Os A; Devereux S; Jebsen P; Bogen B; Tjønnfjord GE; Munthe LA
    J Immunol; 2015 Jan; 194(2):827-35. PubMed ID: 25505279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia.
    Saborit-Villarroya I; Vaisitti T; Rossi D; D'Arena G; Gaidano G; Malavasi F; Deaglio S
    Leukemia; 2011 Mar; 25(3):479-88. PubMed ID: 21212793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory, morphologic, and immunophenotypic correlates of surface immunoglobulin heavy chain isotype expression in B-cell chronic lymphocytic leukemia.
    Shen PU; Fuller SG; Rezuke WN; Sherburne BJ; DiGiuseppe JA
    Am J Clin Pathol; 2001 Dec; 116(6):905-12. PubMed ID: 11764081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia.
    Benkisser-Petersen M; Buchner M; Dörffel A; Dühren-von-Minden M; Claus R; Kläsener K; Leberecht K; Burger M; Dierks C; Jumaa H; Malavasi F; Reth M; Veelken H; Duyster J; Zirlik K
    PLoS One; 2016; 11(12):e0169159. PubMed ID: 28036404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
    Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
    Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9.
    Buggins AG; Levi A; Gohil S; Fishlock K; Patten PE; Calle Y; Yallop D; Devereux S
    Br J Haematol; 2011 Jul; 154(2):216-22. PubMed ID: 21569005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.
    Deaglio S; Vaisitti T; Aydin S; Bergui L; D'Arena G; Bonello L; Omedé P; Scatolini M; Jaksic O; Chiorino G; Efremov D; Malavasi F
    Blood; 2007 Dec; 110(12):4012-21. PubMed ID: 17699742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
    Deaglio S; Vaisitti T; Aydin S; Ferrero E; Malavasi F
    Blood; 2006 Aug; 108(4):1135-44. PubMed ID: 16621959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation.
    Rozková D; Novotná L; Pytlík R; Hochová I; Kozák T; Bartůnková J; Spísek R
    Int J Cancer; 2010 Mar; 126(5):1132-43. PubMed ID: 19685493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.
    Deaglio S; Vaisitti T; Bergui L; Bonello L; Horenstein AL; Tamagnone L; Boumsell L; Malavasi F
    Blood; 2005 Apr; 105(8):3042-50. PubMed ID: 15613544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large changes in NAD levels associated with CD38 expression during HL-60 cell differentiation.
    Al-Abady ZN; Durante B; Moody AJ; Billington RA
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):51-5. PubMed ID: 24216102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD38 in chronic lymphocytic leukemia: from bench to bedside?
    Deaglio S; Vaisitti T; Serra S; Audrito V; Bologna C; D'Arena G; Laurenti L; Gottardi D; Malavasi F
    Mini Rev Med Chem; 2011 Jun; 11(6):503-7. PubMed ID: 21561406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.